Torrent Pharmaceuticals
Torrent Pharma delivered a strong Q3 FY26 with 18% revenue growth to ₹3,333 crore and 19% EBITDA growth to ₹1,088 crore, driven by double-digit expansion in India (+14%) and Brazil (+27% reported, +10% constant curren...
Torrent Pharmaceuticals vs Entero Healthcare Solutions Q3 FY26
Side-by-side earnings comparison across verified financials, sentiment, risks, and management commentary.
Entero Healthcare Solutions
Entero Healthcare delivered a strong Q3 FY26 with revenue of ₹1,771 crore (+26% YoY) and EBITDA of ₹68 crore (+36% YoY), driven by organic growth of 17.1% and contributions from recent medtech acquisitions.
Result Snapshot
Revenue₹3,333 Cr₹1,707 Cr
PAT₹635 Cr₹34 Cr
EBITDA Margin32.9%4%
Sentimentbullishbullish
Key Quotes
Our two largest branded markets, India and Brazil, each continue to deliver healthy double-digit growth. India business grew at 14% and Brazil grew at 27%.
We are on track to deliver our full year guidance.